138
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?

, &
Pages 9-12 | Published online: 12 Jul 2009

  • Saurat JH, Oral isotretinoin. Where now, where next. Dermatology (1997) 195 (suppl 1): 1-3.
  • Meigel WN, How safe is isotretinoin? Dermatology (1997) 195 (suppl 1): 22-8.
  • Goulden V, Layton AM, Cunliffe W, Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol (1994) 131: 360-3.
  • Ortonne JP, Oral isotretinoin treatment policy. Do we all agree? Dermatology(1997) 195 (suppl 1): 34-7.
  • Earth JH, Macdonald-Hull SP, Mark J et al, Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol (1993) 129: 704-7.
  • Gough A, Chapman S, Wagstaff K et al, Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J (1996) 312:169-72.
  • Dominguez-Munoz JE, Junemann F, Malfertheiner F, Hyperlipidemia in acute pancreatitis. Cause or epiphenomenon? Int J PancreatoI(1995) 18:101-6.
  • Lestringant GG, Frossard PM, Agarwal M, Galadari IH, Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL cholesterol. Int J Dermatol (1997) 3:859-62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.